DAP:ETR
Danaher Corp
207,80 €
arrow_upward
+0,14%(+0,30) 1D
27-окт., 17:35:30 GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DAP...
Open
207,30 €
High
209,20 €
Low
207,30 €
Mkt. cap
162,95 млд
Avg. vol.
566,00
Volume
1,10 миң
52-wk high
210,30 €
52-wk low
138,20 €
No. of employees
59 миң
Open
207,30 €
High
209,20 €
Low
207,30 €
Mkt. cap
162,95 млд
Avg. vol.
566,00
Volume
1,10 миң
52-wk high
210,30 €
52-wk low
138,20 €
No. of employees
59 миң
News stories
From web sources and news partners
qz.com
·
24 мүнөт мурун
Market strategist Eric Criscuolo talks whitepaper on NYSE’s unique market model
1470 & 100.3 WMBD
·
3 мүнөт мурун
NYSE moves to bring all-or-nothing options to stocks and company earnings
ChartMill
·
24 мүнөт мурун
S&P 500 Unusual Volume Movers on Oct. 27, 2026
Yahoo Finance
·
36 мүнөт мурун
Why GM is still an automaker despite its move to the Nasdaq
Profile
Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics. The company operates three divisions: biotechnology, which develops products for the development of therapeutics; life sciences, which develops products to identify causes of disease, new therapies, and to test and manufacture new drugs, vaccines and gene editing technologies; and diagnostics, which develops instruments, consumables, and software and services to diagnose diseases. Danaher was founded in 1984 by brothers Steven Rales and Mitchell Rales; it was named after Danaher Creek in Western Montana, where the brothers came up with the idea for the company while fishing.
The company is ranked 180th on the Fortune 500 and 241st on the Forbes Global 2000. Wikipedia
About Danaher Corp